South Korea’s Celltrion Gets UK Approval for Trials of Covid-19 Antibody Drug
The brand of Celltrion is observed on the corporate’s headquarters in Incheon, South Korea, October 28, 2016. REUTERS/Kim Hong-Ji/Information
South Korean regulators on July 17 authorized an early degree medical trial for the drug, making it the rustic’s first such antibody drug to be examined on people.
- Reuters SEOUL
- Closing Up to date: July 30, 2020, eight:04 AM IST
South Korea’s Celltrion Inc on Thursday stated British regulators had given it regulatory popularity of a section I medical trial of its experimental COVID-19 remedy drug.
The corporate will enrol members for a medical find out about in the United Kingdom after approval from the Drugs and Healthcare Merchandise Regulatory Company (MHRA), Celltrion stated in a commentary.
South Korean regulators on July 17 authorized an early degree medical trial for the drug, making it the rustic’s first such antibody drug to be examined on people.
LIVE TV
georegion=104,country_code=IN,region_code=MH,town=MUMBAI,lat=18.98,lengthy=72.83,timezone=GMT+five.50,continent=AS,throughput=vhigh,bw=5000,community=aws,asnum=16509,network_type=hosted,location_id=zero
- Mumbai
- Faridabad
- Ghaziabad
- Gulbarga
- Guntur
- Gurgaon
- Guwahati
- Hyderabad
- Indore
- Jabalpur
- Jaipur
- Jamshedpur
- Jodhpur
- Kanpur
- Kolkata
- Kota
- Kozhikode
- Lucknow
- Ludhiana
- Madurai
- Mysore
- Nagpur
- Noida
- Patna
- Pune
- Raipur
- Ranchi
- Shimla
- Surat
- Thrissur
- Trichy
- Thiruvananthapuram
- Udaipur
- Vadodara
- Visakhapatnam
- Warangal
- Andhra pradesh
- Assam
- Bihar
- Chhattisgarh
- Gujarat
- Haryana
- Himachal pradesh
- Jammu and kashmir
- Jharkhand
- Karnataka
- Kerala
- Madhya pradesh
- Maharashtra
- Odisha
- Punjab
- Rajasthan
- Tamil nadu
- Telangana
- Uttar pradesh
- Uttarakhand
- West bengal
-
FUEL TYPE
PRICE
CHANGE -
Petrol
₹ 87.19/L
+ zero.05 -
Diesel
₹ 80.11/L
+ zero.05
Powered Through
